Castle Biosciences Inc (CSTL): מקדם מחיר להכנסות
The P/S time series on the GURU.Markets chart illustrates the valuation dynamics of Castle Biosciences (CSTL), where the 2.80 level captures the latest values. Growth is driven by the integration of genomic tests into oncology protocols, despite Medicare regulatory risks. Stability is ensured by the non-cyclical nature of diagnostics and insurance coverage, while human capital is sustained by a life-saving mission and the comfort provided in medical centers.
פילוחים אנליטיים של חברת Castle Biosciences Corp (CSTL)
The P/S multiple reflects the market value of the business relative to its revenue, allowing for an assessment of the premium paid for every dollar of sales. By analyzing the historical P/S values for Castle Biosciences (CSTL), an investor can determine whether expectations for expanded insurance coverage and new gastroenterology tests justify the current capitalization, which is critical for mitigating risks during a price correction.
